The Swiss government said on Thursday a U.S. announcement to support waiving intellectual property rights for COVID-19 vaccines was a significant announcement but left many questions unanswered.
“This is an important announcement by the U.S., but many questions remain unanswered about the specific solutions it is considering in this context,” the State Secretariat for Economic Affairs (SECO) said in an emailed statement.
SECO said Switzerland was still convinced that waiving intellectual property rights in the context of the pandemic could not guarantee fair, affordable and rapid access to vaccines, drugs and diagnostic products against COVID-19.
It said Switzerland would examine this new U.S. request and its consequences on the Swiss position, with the United States itself and within the World Trade Organisation.
The director of the UN office for the high commissioner for human rights in New…
G7 nations called for urgent actions to help civilians trapped in Gaza, facing bombardments, displacement…
As Houstonians head to the polls to elect a new mayor and representatives to city…
The US Secretary of State, Antony Blinken, has emphasized the need for the Palestinian Authority…
Delegates from 28 countries, including the US and China met this Wednesday in the first…
Chinese President Xi Jinping said China is willing to cooperate with the US and to…